Adverse events associated with the use of cannabis-based products in people living with cancer: a systematic scoping review.

ABSTRACT:

Purpose

To summarise the extent and type of evidence in relation to adverse events (AEs) associated with the use of cannabis-based products (CBP) in people living with cancer.

Methods

The Joanna Briggs Institute (JBI) methodology for scoping reviews was applied. A search was performed in MEDLINE (Ovid), Embase (Ovid), CINAHL (EBSCOhost), Scopus, Web of Science Core Collections and AMED (Ovid) from their inception to 7 May 2023. Primary studies reporting AEs associated with any form of natural or synthetic CBP use in any cancer care setting and location were included.

Results

One hundred fifty-two studies were included, with the most prevalent being randomised controlled trials (RCTs) (n = 61), followed by non-randomised controlled trials (n = 26) and case reports (n =

SUBMITTER: Cheah I 

PROVIDER: S-EPMC11655613 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature